Largest pharmaceutical companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by earnings, at AED 98.4B, ahead of Eli Lilly (AED 75.8B) and Merck & Co (AED 67B). Figures as of 18 Nov 2026, 19:33 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonAED 98.4B
- Median
- AED 216.7M
- Combined market value
- AED 18.58T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | AED 98.4B | AED 2.42T | AED 1,004.53 | 1.86% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | AED 75.8B | AED 4.53T | AED 5,082.55 | 2.24% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | AED 67B | AED 1.24T | AED 504.33 | 4.22% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | AED 55.8B | AED 637.7B | AED 144.69 | 3.21% down | 17% down | ||
| 5 | NovartisNVS · Health Care | AED 51.4B | AED 1.08T | AED 569.58 | 2.55% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | AED 37.6B | AED 1.02T | AED 655.67 | 2.06% down | 2% up | ||
| 7 | SanofiSNY · Health Care | AED 31.8B | AED 416.2B | AED 173.34 | 0.70% down | 4% down | ||
| 8 | PfizerPFE · Health Care | AED 28.5B | AED 587B | AED 102.99 | 1.51% down | 14% up | ||
| 9 | GSKGSK · Health Care | AED 27.9B | AED 357.8B | AED 178.52 | 1.29% down | 6% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | AED 25.9B | AED 447.4B | AED 218.90 | 2.85% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | AED 24B | AED 664.8B | AED 383.84 | 0.19% down | 17% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | AED 16.5B | AED 359B | AED 3,469.88 | 1.36% down | 36% up | ||
| 13 | AbbVieABBV · Health Care | AED 15.5B | AED 1.85T | AED 1,048.82 | 2.48% down | 26% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | AED 14.5B | AED 500.5B | AED 1,974.24 | 0.62% up | 27% up | ||
| 15 | ZoetisZTS · Health Care | AED 9.8B | AED 127.4B | AED 313.58 | 2.27% up | 29% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | AED 5.2B | AED 180.5B | AED 154.74 | 1.15% down | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | AED 4.9B | AED 90.6B | AED 2,126.22 | 0.89% down | 23% up | ||
| 18 | GenmabGMAB · Health Care | AED 3.5B | AED 116.2B | AED 188.38 | 1.29% down | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | AED 2.8B | AED 146.4B | AED 254.69 | 0.97% up | 78% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | AED 2.5B | AED 18.4B | AED 220.37 | 0.60% down | 20% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | AED 1.7B | AED 45.9B | AED 55.04 | 1.32% up | 5% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | AED 1.6B | AED 36.5B | AED 241.27 | 4.75% up | 107% up | ||
| 23 | GrifolsGRFS · Health Care | AED 1.6B | AED 21.1B | AED 30.93 | 2.42% down | 1% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | AED 1.3B | AED 43.3B | AED 223.78 | 4.14% up | 11% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | AED 1.2B | AED 73.5B | AED 548.42 | 4.59% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | AED 1.1B | AED 169.6B | AED 1,484.36 | 2.20% down | 17% up | ||
| 27 | AlkermesALKS · Health Care | AED 887.6M | AED 28.6B | AED 170.34 | 2.05% up | 58% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | AED 457.1M | AED 22B | AED 1,099.16 | 1.86% up | 43% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | AED 366M | AED 27.2B | AED 248.58 | 3.41% down | 8% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | AED 264.7M | AED 27.9B | AED 80.10 | 3.27% up | 83% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | AED 216.7M | AED 27.4B | AED 348.29 | 0.29% down | 126% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -AED 6M | AED 22.4B | AED 158.72 | 0.52% up | 10% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -AED 85.8M | AED 22.1B | AED 338.45 | 0.22% up | 31% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -AED 93.8M | AED 17.8B | AED 185.49 | 1.16% down | 44% up | ||
| 35 | VeradermicsMANE · Health Care | -AED 257.1M | AED 19.3B | AED 456.42 | 1.09% down | 233% up | ||
| 36 | Belite BioBLTE · Health Care | -AED 285M | AED 23.4B | AED 575.55 | 0.64% down | 31% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -AED 387.2M | AED 23.7B | AED 350.05 | 1.05% down | 241% up | ||
| 38 | ErascaERAS · Health Care | -AED 457.4M | AED 17.3B | AED 49.40 | 3.17% down | 403% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -AED 478M | AED 30.1B | AED 460.79 | 0.63% up | 46% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -AED 570M | AED 34.7B | AED 365.22 | 6.00% up | 286% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -AED 596.2M | AED 17.7B | AED 314.35 | 1.60% down | 113% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -AED 616.3M | AED 16.7B | AED 152.68 | 1.12% down | 88% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -AED 672.8M | AED 25.9B | AED 492.93 | 1.28% down | 7% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -AED 675M | AED 14.4B | AED 105.01 | 2.69% down | 169% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -AED 721.8M | AED 30.6B | AED 441.14 | 3.00% up | 13% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -AED 852.1M | AED 49.3B | AED 98.61 | 3.87% up | 20% up | ||
| 47 | Ascendis PharmaASND · Health Care | -AED 929.2M | AED 65B | AED 990.63 | 0.54% down | 28% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -AED 1.1B | AED 34.3B | AED 1,475.35 | 4.81% down | 24% down | ||
| 49 | Legend BiotechLEGN · Health Care | -AED 1.1B | AED 11.5B | AED 59.35 | 0.31% up | 42% down | ||
| 50 | Roivant SciencesROIV · Health Care | -AED 1.1B | AED 102.2B | AED 141.11 | 0.75% down | 90% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -AED 1.1B | AED 31.5B | AED 1,125.99 | 0.50% up | 61% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -AED 1.2B | AED 18B | AED 103.17 | 0.86% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -AED 1.3B | AED 57.9B | AED 902.63 | 2.10% up | 37% up | ||
| 54 | ABIVAXABVX · Health Care | -AED 1.4B | AED 26.9B | AED 306.86 | 1.77% up | 27% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -AED 1.4B | AED 16.9B | AED 101.52 | 2.52% up | 64% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -AED 2.7B | AED 55.6B | AED 285.17 | 1.10% up | 17% up | ||
| 57 | CytokineticsCYTK · Health Care | -AED 2.9B | AED 26.2B | AED 187.94 | 0.93% down | 20% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -AED 3.5B | AED 249.7B | AED 78.16 | 1.66% down | 54% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -AED 4B | AED 31B | AED 38.82 | 0.94% down | 36% down | ||
| 60 | InsmedINSM · Health Care | -AED 4.7B | AED 96.8B | AED 441.25 | 1.41% down | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -AED 12.9B | AED 86.7B | AED 75.60 | 0.66% up | 96% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6728 AED).
Questions and answers
Which pharmaceutical companies rank first by earnings?
Johnson & Johnson (AED 98.4B), Eli Lilly (AED 75.8B) and Merck & Co (AED 67B) are the top three of the 61 pharmaceutical companies ranked by earnings as of 18 Nov 2026, 19:33 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by earnings.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by earnings have a combined market value of AED 18.58T as of 18 Nov 2026, 19:33 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.